Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2015

Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,733 recalls, newest first.

Class II · Moderate risk

Lisinopril Tablets USP

CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.

Terminated cGMP deviation Wockhardt Usa Inc. NDC 64679-928-06 D-1346-2015
Class III · Low risk

Dexmethylphenidate HCl Extended-Release

Failed Dissolution Specifications: Product is being recalled due to out of specification (above specification) result obtained at 6-hour dissolution time point during the 12-month stability testing.

Terminated Dissolution failure Novartis Pharmaceuticals Corp. D-1430-2015
Class III · Low risk

Hydralazine Hydrochloride Injection

Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)

Terminated Stability / shelf life Fresenius Kabi USA, LLC NDC 63323-614-01 D-1327-2015
Class III · Low risk

CVS Pharmacy

Superpotent Drug: Out Of Specification (OOS) result for Assay.

Terminated Wrong potency / content Ohm Laboratories, Inc. D-0023-2016

Recalls by year